Eurofins CDMO Expands Spray Drying Capabilities

Eurofins CDMO announced the expansion of existing spray dry development and production services in North America. The Canadian facility, located in Mississauga, Ontario, has expanded its cGMP spray drying capabilities with the addition of a GEA Mobile Minor spray drying system and dedicated 500 square foot clean room.
 
With this expansion, Eurofins CDMO can further complement a broad range of services specializing in solubility enhancement for clinical development and small-scale commercial programs. Its process capabilities include solvent or aqueous systems, highly potent compounds, API and drug product development and manufacturing, solid state characterization, oral solid and inhalation dosage forms.
 
The expansion of spray drying at Eurofins CDMO provides continued support of clinical development programs where formulation enabling is required for poorly soluble compounds.
 
The new spray dry system enables manufacturing of solid dispersions at multi-kilo scale in support of a wide range of finished dosage forms for early clinical through to niche commercial programs.